Assessment of cognitive disorders using ultrasound at a day hospital
Official title: Cognitive Disorders and Brain Pulse
Run by University Hospital, Tours · NCT05129150 · Data updated 2026-11-12
This study is testing if ultrasound can help track changes in thinking and memory for patients with cognitive disorders over five years.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University Hospital, Tours Academic / other |
| Locations | 1 site (Tours) |
| Status | Recruiting |
| Started | March 31, 2022 |
| Main results expected | March 2027 |
| Study ends | March 2032 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT05129150 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients undergoing assessment for cognitive functions at the MRRC of the CHU of Tours.
✕Probably not a fit
Patients who refuse the TPI ultrasound examination or oppose data processing will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study involves patients receiving assessments for neurocognitive disorders at the Memory, Resources, and Research Centre (MRRC) in Tours. Patients will undergo a TPI ultrasound examination during their day hospital visit and will be followed up for five years to monitor their cognitive functions. The study aims to evaluate the effectiveness of ultrasound in assessing cognitive disorders over time. Regular consultations will be conducted to ensure comprehensive care and data collection.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of neurocognitive disorders through improved diagnostic techniques.
How similar studies have gone: While the use of ultrasound in cognitive assessments is an emerging field, similar studies have shown promising results in related areas, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient benefiting from a day hospital at the MRRC of the CHU of Tours for assessment of cognitive functions Exclusion Criteria: * Refusal of TPI ultrasound examination * Patients who opposed to data processing * Patients under judicial protection
Where it's running
-
University hospital
Tours, France Recruiting
Study contacts
- Principal investigator: Thomas DESMIDT — University Hospital, Tours
- Study coordinator: Thomas DESMIDT
- Email: t.desmidt@chu-tours.fr
- Phone: 0234378952
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive brain stimulation plus computer-based memory training for mild cognitive impairment
This trial will test whether a short course of non-invasive brain stimulation combined with one of two computer-based brain-training programs helps people aged 60–85 with mild cognitive impairment improve memory, thinking, mood, and daily function.
-
Developing and testing the Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
This project will test a short questionnaire called LiCCoS to see if it can spot thinking and everyday mental problems in adults with liver cirrhosis.
-
Carotid artery wall viscosity and memory problems in older adults
This project will test whether the viscous behavior of the carotid artery wall is linked to memory problems in people over 70 with memory complaints, Alzheimer's disease, or vascular dementia.
-
NeuroFirst brain protection for adults having heart bypass surgery
This trial tests whether a bundled anesthesia approach called NeuroFirst can help people aged 60 and older having planned heart surgery with cardiopulmonary bypass avoid silent brain infarcts and thinking or memory problems after surgery.
-
Nutrition-based interventions to prevent cognitive decline
This study is testing if a 6-month nutrition program can help adults at higher risk for dementia keep their thinking skills sharp.
-
Oral midazolam to help deliver care for older adults with neurocognitive disorders who refuse care
This study will try a short-acting oral midazolam to help nurses and caregivers give essential care to older adults with moderate to severe neurocognitive disorders who resist or refuse care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.